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Amniotic ﬂuid (AF) has become an interesting source of fetal stem cells. However, AF contains heterogeneous and multiple,
partially diﬀerentiated cell types. After isolation from the amniotic ﬂuid, cells were characterized regarding their morphology
and growth dynamics. They were sorted by magnetic associated cell sorting using the surface marker CD 117. In order to show
stem cell characteristics such as pluripotency and to evaluate a possible therapeutic application of these cells, AF ﬂuid-derived
stem cells were diﬀerentiated along the adipogenic, osteogenic, and chondrogenic as well as the neuronal lineage under hypoxic
conditions. Our ﬁndings reveal that magnetic associated cell sorting (MACS) does not markedly inﬂuence growth characteristics
as demonstrated by the generation doubling time. There was, however, an eﬀect regarding an altered adipogenic, osteogenic,
and chondrogenic diﬀerentiation capacity in the selected cell fraction. In contrast, in the unselected cell population neuronal
diﬀerentiation is enhanced.
1.Introduction
Fetal stem cells represent a relatively new cell population
in the ﬁeld of stem cell research, exhibiting unique and
fascinating features, while recent studies have provided new
insights into stem cell biology as well as new putative
strategies to exploit their therapeutic potential. These cells
can be derived from the fetus itself or alternatively from
supportive extraembryonic structures such as the amniotic
ﬂuid [1]. The combination of being extraembryonic and
providing relatively easy access for cell harvesting makes the
amniotic ﬂuid an important alternative source of fetal stem
cells [2, 3].
I ti s ,h o w e v e r ,w e l lk n o w nt h a ta m n i o t i cﬂ u i dr e p r e -
sents a very heterogeneous population that includes cells
derived from the fetal membranes as well as from the fetus
itself. Amniotic ﬂuid- derived cells have been classiﬁed on
the basis of their morphological, biochemical and growth
characteristics, with three groups of amniotic-ﬂuid-derived
cellsidentiﬁedsuchastheepithelial-likecells,amnioticﬂuid-
speciﬁc cells, and ﬁbroblast like cells [4].
At the beginning of the amniotic ﬂuid-derived cell
culture out of the amniotic-ﬂuid-speciﬁc cells preferentially
epithelial-like cells can be found, while ﬁbroblast like cells
usually appear later and not in all ﬂuid samples. These cells
are thought to be derived from the ﬁbrous connective tissue
and dermal ﬁbroblasts [4, 5].
The development of speciﬁc culture protocols for AF-
cells has permitted the isolation and expansion of multipo-
tent stem cells from the amniotic ﬂuid 6. Thus, these stem
cells exhibit typical mesenchymal stem cell markers such as
CD 29, CD 90, CD 166, CD 73, CD 105, CD 49, and CD
117 2, and they are negative for the hemopoietic surface
markers CD 45, CD 34, and CD 14 [6, 7]. Further investi-
gations revealed that these cells also have characteristics of
multipotent stem cells, as demonstrated by the expression of
stem cell markers such as Oct-4 and SSEA-4 [2, 3]. Apart
from the diﬀerentiation potential along the mesodermal
lineage by diﬀerentiation into osteoblasts and chondrocytes
also the diﬀerentiation into the neural lineage has been
documented[6].Furtherinvestigationusing CD117positive2 Stem Cells International
AF-cells have conﬁrmed the potential of these cells to
diﬀerentiate toward neural lineages [2]. In regard of their
pluripotency they are an attractive autologous cell source
for fetal tissue engineering applications. So far, autologous
amniotic ﬂuid cell-based tissue engineered constructs have
been successfully used for neonatal repair of the diaphragm
and for fetal trachea reconstruction [8], and they have
the potential to form fetal heart valve leaﬂets in vitro [9].
An enhanced neural marker expression of immortalized
amniotic ﬂuid cells has been shown after application of
neural induction [10].
Therefore, in our study we have investigated the growth
characteristics of AF cells in diﬀerent culture conditions
obtained from ordinary amniocenteses as well as from
amniodrainages. The focus of our study was the diﬀerenti-
ation potential of AF cells after a cell sorting procedure using
the MACS system on the basis of the surface marker CD 117.
Our data reveal that AF cells from the positive fraction show
improved diﬀerentiation characteristics into the osteogenic
and chondrogenic lineage, while cells from the negative
fraction, favourably show a neural diﬀerentiation capacity.
After intracerebral transplantation in adult rats, cells show a
remarkable integration and diﬀerentiation capacity.
2.MaterialandMethods
2.1. Origin of Amniotic Fluid-Derived Cells. Amniotic ﬂuid
was obtained from human amniocentesis samples. Amnio-
centesis is a clinical routine procedure performed during
week 15–20 of gestation for prenatal diagnosis. It is an
ethically approved and accepted procedure. Alternatively,
amniotic ﬂuidwas takenfrom amniodrainages from patients
with polyhydramnios. Cell samples were only used when
no major abnormalities were revealed by the cytogenetic
analysis. All patients gave written informed consent and
were informed in detail about our procedures for diagnostic
fulﬁllment according to the protocol of this study, which was
approved by the local hospital ethics committee.
2.2. Cell Culture of Amniotic Fluid-Derived Cells. The amni-
otic ﬂuid-derived cells were routinely cultured in Mini-
mum Essential Medium (α-MEM; Invitrogen, Karlsruhe,
Germany) supplemented with 10% fetal bovine serum (FBS,
PAA, C¨ olbe, Germany) in a 100mm culture dish and
incubated at 37◦C with 5% humidiﬁed CO2. Alternatively
cell culture was carried out in advanced Dulbeccos Modiﬁed
Eagles medium (ADMEM, Invitrogen) supplemented with
5% FBS. The ﬁrst medium change was performed after
5 days in order to avoid any mechanical stress. After 10 to
14 days, when the cultureshad reached 80% conﬂuence,cells
were harvested using Accutase (PAA), and were replated at
2000cells/cm2. The cells were kept in culture for up to 6
passages. For the experiments cells were taken from passage
2.
Alternatively to standard culture conditions, amniotic
ﬂuid-derived cells were cultured in an atmosphere with a
reduced O2 tension. Normal humidiﬁed tissue culture incu-
bators with 5% CO2 were used for the 21% oxygen cultures.
For decreased oxygen cultures, plates were cultivated in the
presence of 2% O2.
2.3. Evaluation of Cell Kinetics. Cell kinetics were studied
by determining the generation doubling time of cells from
amniodrainages and amniocenteses as well as from selected
and unselected AF cells. Cells were plated in culture medium
at a density of 1 × 103 cells/cm2 in cell culture dishes and
allowed to multiply until 80% conﬂuence. Adherent AF cells
were thenliftedand countedwith ahaemocytometeratevery
passage. Generation doubling times (GDT) and numbers
(CD) were calculated from hemocytometer counts and cell
culturetime(CT)foreach passageaccordingtothefollowing
2 formulae:
CD =
ln(N1/N2)
ln(2)
,G D T =
CT
CD
(1)
(N1: number of cells at conﬂuence prior to passaging and
N2: number of cells seeded after passaging).
2.4. Construction of HC-Ad Vectors and Cell Labeling. The
high-capacity adenoviral vector (HC-Ad) was generated as
previouslydescribed[11].The vectorHC-Ad.FK7expressing
enhanced GFP (EGFP-enhanced green ﬂuorescent protein)
has also been described [11]. AF cells were infected using
a stock AdV concentration of 2 × 106 infectious units/μL,
corresponding to 50 multiplicities of infection (MOI) for a
single cell. Transduction eﬃciency was analysed 24h after
transduction by determining the population of cells with
EGFP expression within the total cell population labeled by
t h eH o e c h s td y en u c l e a rs t a i n( n o ts h o w n ) .
2.5. Immunoselection for CD117. For immunoselection of c-
Kit-positive cells from single-cell suspensions, the cells were
incubated with a rabbit polyclonal antibody to CD117 (c-
Kit), speciﬁc for the protein’s extracellular domain (amino
acids 23–322) (Santa Cruz Biotechnology, Santa Cruz, CA,
USA).
The CD117-positive cells were puriﬁed by incubation
with magnetic Goat Anti-Rabbit IgG MicroBeads and selec-
tion on a Mini-MACS apparatus (Miltenyi Biotec, Bergisch-
Gladbach, Germany) following the protocol recommended
by the manufacturer. AF cells were subcultured routinely at a
dilution of 1:4 to 1:8 and not permitted to expand beyond
70% of conﬂuence.
2.6. CFU Assay. Following MACS sorting and expansion
CD117+ and CD117− amniotic ﬂuid-derived cells were
plated at 10,50, 100, 500, 1.000, and 10.000 cells/100mm
diameterculturedish.After12daysofculture,cellswereﬁxed
and stained with 1% cresyl violet in 100% methanol. The
number of colonies with >50 cells was counted.
2.7. AF-Cell Diﬀe r e n t i a t i o nI nV i t r o .In vitro diﬀerentiation
was carried out as described previously for mesenchymal
stem cells [12]. Cells were analyzed for their capacity to
diﬀerentiate into the osteogenic and chondrogenic lineage.Stem Cells International 3
Diﬀerentiation was performed in a monolayer. Cells were
plated at a density of 3 × 103 cells/cm2,a n dc u l t u r e da t3 7 ◦C
in a humidiﬁed atmosphere (5% CO2) for various periods.
The medium was changed three times a week.
Osteogenic diﬀerentiation was induced by culturing AF
cells for 3 weeks in osteogenic medium (OM). OM consisted
of DMEM (Invitrogen) containing 10% FCS, 0.05mM
ascorbic acid-2-phosphate, 10mM β-glycerophosphate, and
0.1μM dexamethasone. Osteogenic diﬀerentiation of ASCs
was assessed by evaluating morphological changes and
calciﬁed extracellular matrix (ECM) deposition.
Induction of chondrogenic diﬀerentiation was carried
out in a three-dimensional (3D) pellet culture. For 3D
pellet cultures AF cells were resuspended at a density of
5 × 105 cells/mL. The chondrogenic medium was supple-
mented with insulin-transferrin selenium (ITS) 1:100v/v
(1.0mg/mL insulin from bovine pancreas, 0.55mg/mL
human transferrin, and 0.5μg/mL sodium selenite), 0.1μM
dexamethasone, 0.05mM ascorbic acid, 50μM l-proline,
1mM sodium pyruvate (Sigma, Deisenhofen, Germany).
Cell suspension (500μL) was aliquoted into 15mL polypro-
pylene centrifuge tubes (Eppendorf, Hamburg, Germany),
and centrifugated at 500g for 5min. as described previously
[12]. The chondrogenic medium was supplemented with
5ng/mLofTGF-β1 (Sigma). Fresh medium was added every
third day. The medium without TGF-β1 was used as the
control medium for control 3D culture. The tubes were
placed in the incubator at 37◦C in a humidiﬁed atmosphere
with 5% CO2 for up to 3 weeks. The caps of the tubes were
loosened to allow air exchange.
2.8. Cell Type Examination. For histological staining proce-
dures, cells that were cultivated according to the osteogenic
or chondrogenic induction procedure were ﬁxed with 4%
PFA, dehydrated, embedded in paraﬃn and cut into 5μm
sections. The cells were stained with alkaline phosphatase,
vonKossa ortheAlcianbluestaining inordertodemonstrate
the osteogenic and chondrogenic diﬀerentiation potential,
respectively. For the von Kossa staining the cells were ﬁxed
with 4% formaldehyde for 30min at room temperature. The
cells were rinsed with distilled water and then overlaid with
a 1% (wt/vol) silver nitrate solution in the absence of light
for 30min. The cells were washed several times with distilled
water and were counterstained with nuclear fast red.
2.9.Neural InductionofAmnioticFluid-Derived Cells. Forthe
enhancement of neural diﬀerentiation, amniocyte-derived
cells were transferred to a serum-free medium (DMEM/F12,
Invitrogen) supplemented with the growth and diﬀerentia-
tion factor FGF8 (100ng/mL) in combination with retinoic
acid (RA) 1μM and plated at a density of 2000cells/cm2
on Poly-Ornithine-Laminine coated glass coverslips in 4-
well culture plates. Alternatively, they were cultivated in
DMEM/Hams F12 supplemented with 10% FBS, epidermal
growth factor (EGF, 20ng/mL, R&D systems, Wiesbaden,
Germany), basic ﬁbroblast growth factor (bFGF, 20ng/mL),
and N2 (Invitrogen). Cells were cultivated for 5 days in these
induction media prior to processing for immunocytochemi-
cal investigations.
2.10. Transplantation of EGFP-Labelled AF Cells. For intra-
ventricular injection, adult Wistar rats (250–300g) were
used and were kept in accordance with Federal Government
guidelines. Animals were anesthetized with a mixture of
6mg/kg xylazine and 60 mg/kg ketamine. The animals were
transferred to a stereotactic apparatus. An incision was made
inthescalp3mmlateraltothebregma.Aburrholewasmade
0.3mm caudaland 2.5mm lateraltothebregma using aden-
tal drill. 10μLo fp r e d i ﬀerentiated and GFP labeled AF-cells
were slowly injected into the striatum at a depth of 4.5mm
from the dura [13]. Following human AF-cell injection the
animals received daily subcutaneous cyclosporin A (Sandoz,
Switzerland) injections (10mg/kg). After 7, 14, and 21 days,
rats were sacriﬁced by intracardiac perfusion under deep
anesthesia with xylazine and ketamine in PBS supplemented
with heparin and procainhydrochloride, followed by 4%
formaldehyde. The brains were removed, the forebrains
trimmed, and the samples frozen after cryoprotection in
18% sucrose. Cryostat sections (20μm) were processed
for identiﬁcation of GFP-expressing grafted cells and for
immunoﬂuorescence analysis.
2.11. Immunocytochemical Staining of Cells. For the investi-
gation ofneuralmarkerexpression byamnioticﬂuid-derived
cells, the cells of 5 independent cultures were ﬁxed after
rinsing in 0.1M PBS in 4% PFA. Cryostat sections of the
brain were processed for immunohistochemical analysis as
well. Cells and tissue sections were treated for 30 min. with
a blocking solution composed of 2% goat serum and 5%
FBS. In experiments requiring the labelling of intracellular
epitopes, the cells and tissue sections were further treated
with 0.025% Triton X-100 for 30min and rinsed in PBS.
The primary antibodies used in this study are presented
in Table 1.
Incubations were performed over night at 4◦C. Sec-
ondary antibodies were used at the following dilutions: Cy3
or Cy2-conjugated aﬃnity-puriﬁed goat anti-mouse or anti-
rabbit IgG (Rockland, Gilbertsville, PA, USA) 1:1000.
Anti-GFAP antiserum produced in guinea pig was
detected by Biotin-conjugated goat antiguinea pig (Sigma,
Germany) at a dilution of 1:400 followed by FluoroLink-
TMCyTM3 labelled streptavidin (Amersham Pharmacia
Biotech, Freiburg, Germany) at a dilution of 1:1000. Incu-
bations were performed for 1h at room temperature. After
antibody incubations nuclearDNAwas stained withHoechst
Dye 33342. Preparations were coverslipped with Entellan
(Merck, Darmstadt, Germany). Analysis of mounted spec-
imens was carried out using an Axiophot Fluorescence
microscope (Zeiss, Oberkochen, Germany).
Negative controls were carried out by omitting the
primary antibodies. Speciﬁcity of neural markers was tested
using appropriate cell populations such as neural stem cells
and neural stem-cell-derived neurons and glial cells.
2.12. Statistical Analysis. The cells were viewed using an
AxiophotFluorescencemicroscope(Zeiss,Oberkochen, Ger-
many). Cells in ﬁve consecutive random ﬁelds were counted
for each coverslip. The number of cells was expressed as4 Stem Cells International
Table 1
Antibody Source Dilution
Anti-CD 117, rabbit polyclonal Santa Cruz Biotechnology, Santa Cruz, CA, USA 1:11
Anti-pan Cytokeratin, mAb Abcam, Cambridge, UK 1:40
Anti-α-internexin mAb Chemicon, Temecula, CA, USA 1:1000
Anti-GFAP mAb Sigma, Deisenhofen, Germany 1:400
Anti-β-III-tubulin, antiserum produced in rabbit Covance, Richmond, CA, USA 1:8000
Anti-HNK-1 mAb, hybridoma supernatant, TIB 200 American Type Culture Collection, ManassasVA, USA 1:10
mean ± SD from at least two-to-four coverslips from three
independent experiments. Statistical analysis, including the
evaluation of the ELISA investigations, was carried out
Applying the Students t-test or alternatively the one way
analysis of variance (ANOVA) using the Microcal Origin
software (Northampton, MA, USA).
3.Results
3.1. In Vitro Characterisation of Amniotic Fluid-Derived Cells.
AF cells were allowed to adhere to plastic culture dishes and
were grown for 4-5 passages in α-Modiﬁed Eagles Medium
(α-MEM) supplemented with 10% fetal bovine serum (FBS)
or alternatively in an Advanced Dulbeccos Modiﬁed Eagles
Medium (ADMEM) supplemented with 5% FBS. In both
media the ﬁrst adherent cells could be identiﬁed 24 hours
after plating. Morphological examination revealed that cells
do not form a monolayer of cells adherent to the bottom
of the culture dish. Instead several dense cell clusters can
be observed. After the ﬁrst passage though, a homogenous
cell layer (monolayer) can be seen, however, the resulting
cell population is rather heterogeneous. Growing in islands
or in cell groups, cells revealed polygonal morphologies
establishing close contacts to the neighbouring cells. Besides,
there were also elongated spindle shaped cells, resembling
mesenchymal cells in vitro.
After the ﬁrst passage AF cells show marked morpho-
logical diﬀerences dependent on the culture medium used.
All together the heterogeneity of the cell population was still
apparent, but while cells cultivated in α-MEM with 10%
FBS were mainly spindle shaped with elongated processes,
cells cultivated in ADMEM with 5% FBS had a morphology
resembling epithelial cells in vitro (Figures 1(a) and 1(b)).
The proliferation capacity of AF cells was compared
along with the cultivation in the two diﬀerent culture
media. In both media the generation doubling time could
be determined as 30 to 40 hours. While in the medium (α-
MEM) supplemented with 10% FBS cells revealed a stable
proliferation rate until day 60 in passage 10, while with cells
cultivated in ADMEM supplemented with 5% FBS a stable
g r o w t hc o u l do n l yb eo b s e r v e du n t i ld a y3 0o rt h e4 t ht o
5th passage (Figures 1(c) and 1(d)). Because of these more
stable culture conditions for further experiments only cells
cultivated in α-MEM (10% FBS) were used.
As a next step cell growth of cells derived from ordinary
amniocentesis was compared with that of cells obtained
from amniodrainages. As the volume of the amniotic
ﬂuid from the amniodrainages was 1000-fold higher than
that from amniocenteses, consequently the cell yield of
amniodrainages was also markedly higher. Morphologically,
in culture dishes from amniodrainages huge amounts of
desquamated epithelial cells could be found. However,
despite of the markedly higher original cell number in
amniodrainage-derivedpreparationsthecelldensityofabout
700–1200cells/cm2 was similar between the two cell pop-
ulations. Comparing the long-term culture of both cell
populations it was evident that the growth characteristics of
cells derived from amniocenteses is more constant with an
average survival time of 60 to 80 days. Consequently, for our
further experiments only those cells were used (Figures 1(e)
and 1(f)).
3.2.MagneticBead-AssociatedCell Separation. Animmunos-
electionprocedurewith magnetic microspheres (MACS)was
carried out in order to isolate the c-Kit−(CD 117) positive
stem cell population from the heterogeneous amniotic ﬂuid-
derived specimens as CD 117 is considered to be speciﬁc for
mesenchymal stem cells [2]. After the selection procedure
the percentage of CD117 + cells was 3.2 ± 1.03% of
the total cell population. Furthermore, after cell separation
morphologically the CD117+ cell fraction revealed the
typical features of mesenchymal stem cells with elongated
cell bodies (Figure 2(a)), while the CD117− cell fraction
consisted of cells revealing a polymorph morphology resem-
bling epithelial cells in vitro (Figure 2(b)), using immuno-
cytochemistry these latter cells could be shown to express
cytokeratin typical for epithelial cells (inset in Figure 2(b)).
The generation doubling time was evaluated in unselected
cellsaswellasintheCD117positiveandtheCD117negative
cell fraction. Data from the growth dynamics reveal that the
generation doubling time with an average of 30–40 hours is
not altered after the selection procedure. It remains constant
until day 60 in culture (not shown).
3.3. CFU Assay. The potential of self-renewal was analyzed
by use of the CFU assay. Cells were plated at a density of
10, 50, 500, 1.000, 5.000, and 10.000 cells/100-mm culture
dish and were expanded for12days.Individual colonieswere
generated even when AF cells were plated at low densities
such as5 and 10cells/culturedish. The mean rate was30% of
the starting AF-cell population, indicating a subpopulation
of cells with self-renewing capacity in vitro. There were no
diﬀerences between CD117+ and CD117− cells (Figure 3).
3.4. In Vitro Diﬀerentiation Potential of AF Cells. To investi-
gatemultipotentialityofamnioticﬂuidderivedcells,AF-cellsStem Cells International 5
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Figure 1: Morphology and growth characteristics of AF cells under diﬀerent culture conditions. (a) AF cells cultivated in the presence of
α-MEM supplemented with 10% FBS exhibit an elongated morphology. (b) In the presence of ADMEM with 5% FBS cells revealed a rather
epithelioid shape. (c) Cells cultivated in α-MEM (10% FBS) showed a more homogenous generation doubling time (GDT) (d) compared
with those cultivated in ADMEM (5% FBS) (n = 5). (e) The GDT of cells derived from amniocenteses is rather homogenous with an
average survival time of 60–80 days. (f) Cells derived from amniodrainages reveal somewhat longer survival times than cells derived from
amniocenteses and their growth dynamics are inhomogenous(n = 5). Scale bar in a and b = 25μm.6 Stem Cells International
(a) (b)
Figure 2: Morphological analysis of CD117+ and CD117− AF cells. (a) CD117+ cells reveal the typical elongated morphology of
mesenchymal stem cells, (b) CD117− AF cells display a rather polymorph appearance of epithelial cells in vitro, inset, CD117− cells can be
stained by the epithelial marker cytokeratin (red ﬂuorescence) in a counterstain with the nuclear marker Hoechst dye (blue), scale bar in a
and b = 25μm ,a n di nt h ei n s e ti nb= 15μm.
(a) (b)
Figure 3:CFU assayforthe demonstrationand comparisonofthe self-renewing potential ofCD117− and CD117+ AF-cells. Platingofvery
low cell numbers leads to the generation of single colonies (CFU) as demonstrated by the cresyl violet staining. (a) Colony formation after
plating of 1000 CD117(−) cells per 100mm culture dish. (b) Colony formation after plating of 1000 CD117(+) cells per dish. Scale bar =
1cm.
were cultivated in speciﬁc induction media for the char-
acterisation of the osteogenic, chondrogenic and neuronal
diﬀerentiation potential in vitro.
The osteogenicpotential ofthe cellpopulation wastested
after a cultivation period of 21 days under conditions which
were suitable to induce the diﬀerentiation of MSCs into
t h eo s t e o g e n i cl i n e a g e1 2 .I nt h ep r e s e n c eo fa s c o r b a t e ,
dexamethasone, and β-glycerophosphate, cells proliferated
rapidly and formed densely packed colonies. In culture,
dense granular areas appeared within individual colonies
and over the time multiple layers of cells often formed in
these cultures. Osteogenic diﬀerentiation was evaluated in
unselectedAFcellsaswellasintheCD117+andtheCD117−
cell fraction. There was a markedly stronger ALP staining
intensity in the CD117+cell population than in the CD117−
or in the unselected cell fraction (n = 5) (Figures 4(a)–4(c)).
Similar to the ALP activity, a continuous increase in
calcium deposition as analysed by the von Kossa staining
could be demonstrated (not shown). Adipogenic diﬀerenti-
ation was similarly evaluated using the Red Oil O staining
(n = 5). While in CD117− cells there is no adipogenic
diﬀerentiation detectable, this is most prominent in the
CD117+ cell fraction. Unselected cells reveal a moderate
adipogenic diﬀerentiation capacity (Figures 4(d)–4(f)).
Chondrogenic diﬀerentiation was induced using a three-
dimensional pellet culture [14]( n = 5). Under these con-
ditions three-dimensional cell aggregates could be detected
already two days after chondrogenic induction.
The aggregates gradually increased in size over the
total cultivation period of three weeks. After that time
the aggregates were ﬁxed, cryoprotected, and embedded in
Tissue Tec and frozen at −80◦C. Cryosections of the pellets
were stained using the Alcian Blue staining speciﬁc for pro-
teoglycans (Figures 4(g)–4(i)). According to the osteogenic
diﬀerentiation also with the chondrogenic diﬀerentiation
there is a markedly stronger Alcian blue staining intensityStem Cells International 7
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Figure 4: In vitro diﬀerentiation potential of AF cells into the osteogenic (ALP staining), adipogenic, and chondrogenic (Alcian blue
staining) lineage. (a) while there was only a weak ALP staining in the CD117− cell fraction, (b) this was markedly stronger in the CD117+
cell population. (c) Unselected AF-cells also reveal a rather weak osteogenic diﬀerentiation as demonstrated by a weak ALP staining. (d)
While no adipogenic diﬀerentiation as demonstrated by the Oil RedO staining could be observed in the CD117− cell fraction, (e) strong
positive Oil Red O stainingcould be observed in the CD117+ fraction,(f) in the unselected population onlya minornumber ofcells showed
a Red Oil O positive staining.(g) After chondrogenic induction in CD 117 negative cells there is a diﬀuse Alcian blue stainingdetectable. (h)
After chondrogenic induction the CD 117 positive cell fraction forms a ﬁrm pellet with a strong Alcian blue staining in the cortical zone.
The pellets have a hyaline cartilage-like morphology based on characteristic lacunae formationcontaining round to oval shaped cells which
resemble chondrocytes, which occur singly or in nests oftwo to three cells. (i) Diﬀuse Alcian blue stainingcan also be detected in unselected
cells. (j) Densitometric analysisof Alcian blue stainingin the diﬀerent experimental groups There is a signiﬁcanthigher stainingintensity in
the CD117+ cell fraction compared to unselected or CD117 − cells (n = 6). Scale bar in (a–i) = 100μm, in the insets in (g–i) = 50μm.8 Stem Cells International
(a) (b) (c)
Figure 5: Neural marker expression as a proof for the neural diﬀerentiation potential. After the neural selection procedure the expression
of the neural markers such as (a) α-internexin, (b) βIII tubulin, (c) as well as GFAP can be shown. Secondary antibodies for all primary
antibodies are Cy2 conjugated (red ﬂuorescence). Cell nuclei are labelled with the Hoechst dye 33342nuclear stain (blue ﬂuorescence). Scale
bar in (a–c) = 10μm.
in the CD117+ cell fraction compared to the unselected
and CD117− cell population. In case of the CD117+ cell
population this is signiﬁcantly stronger (P<. 05) than in
appropriate control cells cultivated without chondrogenic
diﬀerentiation factors (Figure 4(j)).
In order to further prove the diﬀerentiation potential
of AF cells and to establish their possible application
in cell-based therapies for neurodegenerative diseases also
their neuronal diﬀerentiation capacity was evaluated in the
CD117+ as well as in CD117− and unselected cells.
Neuronal diﬀerentiation was carried out in the presence
of neuronal induction factors as well as under hypoxic
conditions (2% pO2). The neuronal diﬀerentiation potential
of CD117− and stimulated cells was analysed using speciﬁc
neural markers such as βIII tubulin, alpha internexin, and
GFAP (Figure 5). Furthermore, the increase in neuronal
diﬀerentiation after neuronal induction was quantiﬁed
compared to unselected cells as well as CD117+ cells by
determination oftheexpression oftheearly neuronal marker
HNK-1 [15]. Evaluation of the HNK-1 expression revealed
that there is a signiﬁcantly stronger expression of this marker
in the negative cell fraction than in the unselected as well as
in the CD117+ cell population (Figure 6).
3.5. Neuronal Characteristics of AF Cells after CNS Trans-
plantation. GFP-expressing AF cells cultured in selection
medium were injected stereotactically into the striatum of
adult Han Wistar rats. One week after injection, cells could
be easily identiﬁed by their GFP expression in histological
sections of the injection site (Figure 7(a)). At that time
cells revealed a round and uniform morphology without
any processes, which is typical for undiﬀerentiated cells
[16]. Over a period of 1–3 weeks following grafting, cells
could be detected at various locations. Cells had the typical
morphology of neural cells with neurite-like processes. At 2
weeks after grafting, the majority of EGFP-expressing cells
were arranged in cell clusters and are partially coexpressing
GFAP (Figure 7(b));at 3weeks after grafting a dissemination
of cells was visible. Morphological investigations revealed
typical neuronal morphologies with prominent processes
(Figures 7(c) and 7(d)). Immunoﬂuorescence analysis using
an antibody against GFAP revealed a morphological integra-
tion of EGFP-labeled AF cells into the environment of host
cells within the striatum, preferentially in the subventricular
spacewithaclearcolabelingofGFPandGFAP(Figures7(e)–
7(g)).
4.Discussion
It is demonstrated that culture conditions and derivation
of amniotic ﬂuid cells are decisive for the cultivation and
expansion of certain subtypes of heterogenous AF derived
cells.
According to reports in the literature, a high serum
content (20% FBS) in conjunction with the alpha MEM
medium promotes a mesenchymal phenotype of cells [6].
In our investigation these cells reveal rather constant growth
characteristics, while the use of ADMEM with a serum con-
tent as low as 5% results in the enrichment of a more epithe-
lial cell population without any uniform growth dynamics.
Furthermore, in order to obtain a more homogenous cell
population, the method of amniotic ﬂuid retrieval is rather
important. If the ﬂuid is obtained from amniodrainages,
the cellular yield of intact mesenchymal cells is rather low.
Instead, there is a large amount of desquamated epithelialStem Cells International 9
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Figure 6: HNK-1 expression in AF cells as a conﬁrmation of neuronal diﬀerentiation capacity in the CD 117 positive and negative cell
fraction and under hypoxic (2% O2) culture conditions. (a) Moderate HNK-1 (orange ﬂuorescence, arrow) expression in unselected cells
and (b) a weak expression of the early neuronal marker HNK-1 (arrow). (c) While there is a stronger HNK-1 expression in CD 117 negative
cellfractiondetectable (arrows),(d)graphicaldisplayaboutthequantiﬁcationofHNK-1expressionintheunselected, CD117+andCD117−
cell fractions. (∗)signiﬁcant increase of HNK-1 immunopositive cells compared to control. Secondary antibodies are Cy2 conjugated (red to
orange ﬂuorescence. The whole cell population is detected with the Hoechst dye nuclear stain (blue ﬂuorescence) (n = 5, P<. 05). Scale bar
in (a–f) = 25μm.
cells which disturbs the adherence of intact cells. The
adherent cells also reveal rather inhomogeneous growth
dynamics. To our knowledge this is the ﬁrst comparison of
cells derived from either amniodrainages in order to relieve
a polyhydramnios or from the amniotic ﬂuid under normal
conditionsfrom patients during pregnancy between the 15th
and the 20th week of gestation.
In order to obtain a more homogenous cell population
and to isolate mesenchymal stem cells, one option is a
surface marker associated cell sorting as realized by the
MACS technology. However, the surface markers observed
for AF cells are not consistent among reports from diﬀerent
groups. While some laboratories have found that AF cells
are negative for CD117 [6, 17], another group was able to
isolateAFcellswithCD117-boundedmagneticmicrospheres
[2]. However, the expression levels of other surface markers
such asCD105havealsobeenfoundtodiﬀeramongresearch
groups. Some groups have found that CD105 is strongly
expressed in AF cells [2, 17], while another group reported
that CD105 is only weakly expressed [6]. Because there are
so many diﬀerent reports about the expression proﬁle of AF
cells, there is the need for an indepth investigation to further
characterize these cells. Our results indicate that only about
2–5% of the total cell population was positive for CD117.
However, after cell separation the CD117+ cell fraction
revealedthetypicalfeaturesofmesenchymal stemcells,while
the negative population has a rather epithelial morphology.
In contrast, surprisingly all three cell populations: the
unselected cells, the CD 117 positive cell fraction as well as
theCD117negativecellsshowsimilargrowthcharacteristics.10 Stem Cells International
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Figure 7: Integration and diﬀerentiation of GFP labelled (green ﬂuorescence) prediﬀerentiated CD117− AF cells after grafting into the
striatumofadultrats.(a)GFP labelled cells canbe foundaroundtheinjection siteinthestriatum.(b)oneweek aftergraftingGFP expressing
cells arestillarrangedinclustersneartheinjection site,in acostainingwith theastrocyte markerGFAP (Cy2conjugatedsecondaryantibody,
red ﬂuorescence) (c) and (d) typical neural cell morphologies of GFP expressing cells with elongated processes can be detected 2 weeks after
grafting in a costaining with the early neuronal marker α-internexin (Cy2,red), (e) a dense network of GFP expressing processes are visible,
(f) which show a co-staining with the astrocyte marker GFAP (Cy2, red). (g) Overlay of GFP (green) and GFAP (red) expressing cells. Scale
bar in (a) = 20μm, in (b) = 15μm and in (c) and (d) = 10μm.Stem Cells International 11
This indicates that although the cell population within the
amniotic ﬂuid is heterogenous, a coexistence of various cell
populations is possible.
The diﬀerentiation potential of CD 117 positive and
negative cells, respectively, was studied by their adipogenic,
osteogenic,chondrogenic as well as their neuronal diﬀerenti-
ation potential.Unsurprisingly, theCD117 positive cellfrac-
tions revealed markedly better adipogenic, osteogenic as well
as chondrogenic diﬀerentiation characteristics compared to
thenegativeorunselectedAFcells.Thesedataagain showthe
mesenchymal properties of the selected cell population and
are thus in accordance to previous reports about the broadly
pluripotent quality of AF cells [14, 18].
In contrast the neuronal diﬀerentiation potential, as
demonstrated by the expression ofthe early neuronal marker
HNK-1,is higher in the CD 117 negative cell fraction than in
the CD 117 positive cell population. This is in sharp contrast
t ot h er e p o r tb yD eC o p p ie ta l .[ 2], who have shown that
the CD 117 positive cells show a neuronal diﬀerentiation
potential.
This discrepancy may partially be caused by the great
heterogeneity of the original cell population as well as by
the culture conditions, including the serum batch used. On
the other hand as already described earlier there are studies
applying ﬂow cytometry, which reveal that amniotic ﬂuid
cells are negative for CD117 [6]. In fact, this may actually
indicate that there are two diﬀerent stem cell populations
present in the amniotic ﬂuid, one which is CD117+ and
another one which is CD117−. The latter would be the
one in our study with an improved neuronal diﬀerentiation
potential. Anyway, as both CD117+ and CD117− amniotic
ﬂuidcellsisolatedinourstudyshowaself-renewing property
and show a multidiﬀerentiation potency, the quality and the
methodological approach including the isolation procedure
are comparable and as reliable as those described in the
current literature.
Neuronal characteristics of amnion ﬂuid-derived cells
have also been described earlier by our and other groups
[10, 19]. Neuronal diﬀerentiation in our study was carried
out under hypoxic culture conditions as it is known that
hypoxia stimulates neuroregeneration in the ischemic brain
[20].
The feature of neuronal properties and neuronal dif-
ferentiation characteristics can also be conﬁrmed by our
transplantation studies. After GFP labelling in order to
unequivocally detect amniotic ﬂuid- (AF-) derived cells,
integration into various parts of the central nervous com-
partment can be demonstrated. Cells reveal the typical
characteristics of neural cells with a multitude of processes.
Additionally, cells also coexpress several neuronal and glial
markers such as GFAP indicating their integration and
also their in situ diﬀerentiation along the neural lineage.
These data are in line with earlier reports about the
integrative capacity of AF cells in the rat brain [21]a n do u r
own observations concerning the neuronal diﬀerentiation
potential of bone marrow-derived mesenchymal stem cells
andtheirintegrationpropertiesaftertransplantation intothe
adult rat brain [13].
5.Conclusion
Altogether, our data reveal the multipotentiality of stem cells
from the amniotic ﬂuid, which emphasizes that amniotic
ﬂuid cells could be of interest as an alternative source of
stem cells for the treatment of various diseases. However,
dependent on the desired cell diﬀerentiation or therapeutic
application the separation procedure has to be adapted
accordingly. While mesenchymal cells rather diﬀerentiate
into the osteogenic, adipogenic, or chondrogenic lineage,
the remaining cell population including epithelial cells can
be favourably directed into the neural lineage. Especially, in
neonatal medicine stem cells from the amniotic ﬂuid can
be applied as an autologous cell source for diseases that
have to be treated directly after birth such as osteogenic or
chondrogenic defects as well as neurodegenerative diseases
including the retinopathy of prematurity.
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